Albert Maguire
For developing a therapy for inherited retinal degeneration that became the first FDA-approved gene therapy for a genetic disease.
Afiliado al momento del premio
Philadelphia, Estados Unidos
Reconocimiento al trabajo con impacto duradero
For developing a therapy for inherited retinal degeneration that became the first FDA-approved gene therapy for a genetic disease.
Philadelphia, Estados Unidos